MMC, a TekniPlex Business, Unveils ICONect Smart Factory Platform at K -2025 8-09-2025, 22:00

Io Therapeutics, Inc., presented data from studies of IRX4204, the company’s phase II clinical development stage, highly selective third generation RXR nuclear receptor agonist compound, supporting its potential use for prevention and treatment of normal 10-07-2024, 07:00

Movement tích hợp Avant để mở khóa lợi suất cấp độ tổ chức cho người dùng phổ thông 16-04-2026, 03:13